Literature DB >> 18501998

The 2007 ESPEN Sir David Cuthbertson Lecture: amino acids between and within organs. The glutamate-glutamine-citrulline-arginine pathway.

Nicolaas E P Deutz1.   

Abstract

In daily practice, the plasma concentration of amino acids is usually viewed as a parameter of production. However, both a high production and/or a reduced disposal capacity can result in an increased plasma concentration. In this presentation, I will discuss my research on interorgan relationships of the amino acids glutamate, glutamine, citrulline and arginine to explain the regulation of the plasma arginine level. The reduced glutamine disposal during liver failure is related to enhanced plasma glutamine level without any change in muscle and gut production or consumption rate. In contrast during sepsis, a small reduction in plasma glutamine is related to a substantially enhanced organ glutamate and glutamine production or consumption rate. These observations are a good example that plasma levels are directly related to production or consumption rates. Because glutamine breakdown in the gut produces citrulline, there is a good relation between the amount of metabolically active gut tissue and gut and whole body citrulline production. Arginine is produces from citrulline in the kidney and a reduced gut glutamine to citrulline conversion during sepsis explains the reduced de novo arginine production that is related to the reduced plasma arginine level. The interorgan route between muscle, gut, liver and kidney of the amino acids glutamate, glutamine, citrulline and arginine is a very good example of how complicated the regulation of plasma amino acid levels can be. However, in-depth research is necessary and will give us important clues to new nutritional strategies.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18501998     DOI: 10.1016/j.clnu.2008.03.010

Source DB:  PubMed          Journal:  Clin Nutr        ISSN: 0261-5614            Impact factor:   7.324


  19 in total

1.  Is glutamine still an important precursor of citrulline?

Authors:  G C Ligthart-Melis; N E P Deutz
Journal:  Am J Physiol Endocrinol Metab       Date:  2011-05-10       Impact factor: 4.310

2.  A randomized trial of intravenous glutamine supplementation in trauma ICU patients: response to the comments by Ozcelik et al.

Authors:  Jon Pérez-Bárcena; Abelardo García-de-Lorenzo; Antonio Buño; Juan A Llompart-Pou
Journal:  Intensive Care Med       Date:  2014-08-06       Impact factor: 17.440

3.  Enhanced anabolic response to milk protein sip feeding in elderly subjects with COPD is associated with a reduced splanchnic extraction of multiple amino acids.

Authors:  M P K J Engelen; C L N De Castro; E P A Rutten; E F M Wouters; A M W J Schols; N E P Deutz
Journal:  Clin Nutr       Date:  2012-06-06       Impact factor: 7.324

4.  Long-term intermittent glutamine supplementation repairs intestinal damage (structure and functional mass) with advanced age: assessment with plasma citrulline in a rodent model.

Authors:  A M Beaufrère; N Neveux; P Patureau Mirand; C Buffière; G Marceau; V Sapin; L Cynober; D Meydinal-Denis
Journal:  J Nutr Health Aging       Date:  2014-11       Impact factor: 4.075

5.  Effect of intermittent glutamine supplementation on skeletal muscle is not long-lasting in very old rats.

Authors:  D Meynial-Denis; A-M Beaufrère; M Mignon; P Patureau Mirand
Journal:  J Nutr Health Aging       Date:  2013       Impact factor: 4.075

6.  Glutamine: precursor or nitrogen donor for citrulline synthesis?

Authors:  Juan C Marini; Inka Cajo Didelija; Leticia Castillo; Brendan Lee
Journal:  Am J Physiol Endocrinol Metab       Date:  2010-04-20       Impact factor: 4.310

7.  Arginine and ornithine are the main precursors for citrulline synthesis in mice.

Authors:  Juan C Marini
Journal:  J Nutr       Date:  2012-02-08       Impact factor: 4.798

Review 8.  Glutamine metabolism in advanced age.

Authors:  Dominique Meynial-Denis
Journal:  Nutr Rev       Date:  2016-03-02       Impact factor: 7.110

9.  Alterations in whole-body arginine metabolism in chronic obstructive pulmonary disease.

Authors:  Renate Jonker; Nicolaas Ep Deutz; Marcia L Erbland; Paula J Anderson; Mariëlle Pkj Engelen
Journal:  Am J Clin Nutr       Date:  2016-05-04       Impact factor: 7.045

10.  Metabolic phenotyping using kinetic measurements in young and older healthy adults.

Authors:  Nicolaas E P Deutz; John J Thaden; Gabriella A M Ten Have; Dillon K Walker; Mariëlle P K J Engelen
Journal:  Metabolism       Date:  2017-10-03       Impact factor: 8.694

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.